Multifactorial Analysis of Influences on Quality of Life in Cancer Patients
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethical Statement
2.2. Study Design and Setting
2.3. Study Population
2.4. Study Tools
2.5. Statistical Analysis
3. Results
4. Discussion
4.1. Quality of Life and Soliciting Nutritional Information
4.2. Quality of Life and Reduced Food Intake
4.3. Quality of Life and Types of Nutrition Support
4.4. Quality of Life and Age
4.5. Quality of Life and Gender
4.6. Quality of Life and Seeking Consultation with a Dietitian
4.7. Quality of Life and Place of Residence
4.8. Quality of Life and Education Level
4.9. Study Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Munoz-Pineiro, M.A.; Stepien, M.; Randi, G.; Louro, C.S. Cancer in 2040: Estimates for an Ageing Europe. JRC Publications Repository. Available online: https://publications.jrc.ec.europa.eu/repository/handle/JRC133792 (accessed on 6 April 2024).
- Dyba, T.; Randi, G.; Bray, F.; Martos, C.; Giusti, F.; Nicholson, N.; Gavin, A.; Flego, M.; Neamtiu, L.; Dimitrova, N.; et al. The European Cancer Burden in 2020: Incidence and Mortality Estimates for 40 Countries and 25 Major Cancers. Eur. J. Cancer 2021, 157, 308–347. [Google Scholar] [CrossRef] [PubMed]
- Europe’s Beating Cancer Plan Communication from the Commission to the European Parliament and the Council. Available online: https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf (accessed on 15 June 2024).
- Hofmarcher, T.; Lindgren, P.; Wilking, N.; Jönsson, B. The Cost of Cancer in Europe 2018. Eur. J. Cancer 2020, 129, 41–49. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. WHOQOL—Measuring Quality of Life | The World Health Organization. Available online: https://www.who.int/toolkits/whoqol (accessed on 17 September 2024).
- Salvetti, M.d.G.; Machado, C.S.P.; Donato, S.C.T.; da Silva, A.M. Prevalence of Symptoms and Quality of Life of Cancer Patients. Rev. Bras. De Enferm. 2020, 73, e20180287. [Google Scholar] [CrossRef] [PubMed]
- Arndt, V.; Koch-Gallenkamp, L.; Jansen, L.; Bertram, H.; Eberle, A.; Holleczek, B.; Schmid-Höpfner, S.; Waldmann, A.; Zeissig, S.R.; Brenner, H. Quality of Life in Long-Term and Very Long-Term Cancer Survivors versus Population Controls in Germany. Acta Oncol. 2017, 56, 190–197. [Google Scholar] [CrossRef] [PubMed]
- Gurevich, M.; Devins, G.M.; Rodin, G.M. Stress Response Syndromes and Cancer: Conceptual and Assessment Issues. Psychosomatics 2002, 43, 259–281. [Google Scholar] [CrossRef]
- Koutrouli, N.; Anagnostopoulos, F.; Potamianos, G. Posttraumatic Stress Disorder and Posttraumatic Growth in Breast Cancer Patients: A Systematic Review. Women Health 2012, 52, 503–516. [Google Scholar] [CrossRef]
- Kangas, M.; Henry, J.L.; Bryant, R.A. Posttraumatic Stress Disorder Following Cancer. Clin. Psychol. Rev. 2002, 22, 499–524. [Google Scholar] [CrossRef]
- Ciążyńska, M.; Pabianek, M.; Szczepaniak, K.; Ułańska, M.; Skibińska, M.; Owczarek, W.; Narbutt, J.; Lesiak, A. Quality of Life of Cancer Patients during Coronavirus Disease (COVID-19) Pandemic. Psycho Oncol. 2020, 29, 1377–1379. [Google Scholar] [CrossRef]
- Jeppesen, S.S.; Bentsen, K.K.; Jørgensen, T.L.; Holm, H.S.; Holst-Christensen, L.; Tarpgaard, L.S.; Dahlrot, R.H.; Eckhoff, L. Quality of Life in Patients with Cancer during the COVID-19 Pandemic—A Danish Cross-Sectional Study (COPICADS). Acta Oncol. 2021, 60, 4–12. [Google Scholar] [CrossRef]
- Baffert, K.-A.; Darbas, T.; Lebrun-LY, V.; Pestre-Munier, J.; Peyramaure, C.; Descours, C.; Mondoly, M.; Latrouite, S.; Bignon, E.; Nicouleau, S.; et al. Quality of Life of Patients with Cancer during the COVID-19 Pandemic. In Vivo 2021, 35, 663–670. [Google Scholar] [CrossRef]
- Bargon, C.; Batenburg, M.; Van Stam, L.; van der Molen, D.M.; Van Dam, I.; van der Leij, F.; Baas, I.; Ernst, M.; Maarse, W.; Vermulst, N.; et al. The Impact of the COVID-19 Pandemic on Quality of Life, Physical and Psychosocial Wellbeing in Breast Cancer Patients—A Prospective, Multicenter Cohort Study. Eur. J. Cancer 2020, 138, S17. [Google Scholar] [CrossRef]
- Tabaczynski, A.; Bastas, D.; Whitehorn, A.; Trinh, L. Changes in Physical Activity and Associations with Quality of Life among a Global Sample of Cancer Survivors during the COVID-19 Pandemic. J. Cancer Surviv. 2022, 17, 1191–1201. [Google Scholar] [CrossRef] [PubMed]
- Gallo, O.; Bruno, C.; Locatello, L.G.; Martelli, F.; Cilona, M.; Orlando, P.; Fancello, G.; Maggiore, G.; Viberti, F.; Ciabatti, P.; et al. The Impact of the COVID-19 Pandemic on the Quality of Life of Head and Neck Cancer Survivors. Support. Care Cancer 2021, 29, 6297–6304. [Google Scholar] [CrossRef] [PubMed]
- Helm, E.E.; Kempski, K.A.; Galantino, M.L.A. Effect of Disrupted Rehabilitation Services on Distress and Quality of Life in Breast Cancer Survivors during the COVID-19 Pandemic. Rehabil. Oncol. 2020, 38, 153–158. [Google Scholar] [CrossRef]
- Wintner, L.M.; Sztankay, M.; Aaronson, N.; Bottomley, A.; Giesinger, J.M.; Groenvold, M.; Petersen, M.A.; van de Poll-Franse, L.; Velikova, G.; Leeuw, I.V.-D.; et al. The use of EORTC measures in daily clinical practice—A synopsis of a newly developed manual. Eur. J. Cancer 2016, 68, 73–81. [Google Scholar] [CrossRef]
- Marshall, K.M.; Loeliger, J.; Nolte, L.; Kelaart, A.; Kiss, N.K. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin. Nutr. 2019, 38, 644–651. [Google Scholar] [CrossRef]
- Gomes, F.; Baumgartner, A.; Bounoure, L.; Bally, M.; Deutz, N.E.; Greenwald, J.L.; Stanga, Z.; Mueller, B.; Schuetz, P. Association of nutritional support with clinical outcomes among medical inpatients who are malnourished or at nutritional risk: An updated systematic review and meta-analysis. JAMA Netw. Open 2019, 2, e1915138. [Google Scholar] [CrossRef]
- Groenvold, M.; Klee, M.C.; Sprangers, M.A.; Aaronson, N.K. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J. Clin. Epidemiol. 1997, 50, 441–450. [Google Scholar] [CrossRef]
- Scott, N.; Fayers, P.; Aaronson, N.; Bottomley, A.; de Graeff, A.; Groenvold, M.; Gundy, C.; Koller, M.; Petersen, M.A.; Sprangers, M.A.G. EORTC QLQ-C30. Reference Values. Brussels: EORTC. 2008. Available online: https://www.eortc.org/app/uploads/sites/2/2018/02/reference_values_manual2008.pdf (accessed on 15 June 2024).
- EORTC QLQ-C30. Quality of Life of Cancer Patients. Translations. Available online: https://qol.eortc.org/questionnaire/eortc-qlq-c30/ (accessed on 19 July 2024).
- Arraras, J.I.; Greimel, E.; Sezer, O.; Chie, W.C.; Bergenmar, M.; Costantini, A.; Young, T.; Vlasic, K.K.; Velikova, G. An international validation study of the EORTC QLQ-INFO25 questionnaire: An instrument to assess the information given to cancer patients. Eur. J. Cancer 2010, 46, 2726–2738. [Google Scholar] [CrossRef]
- EORTC QLQ–INFO25—Quality of Life of Cancer Patients Translations. Available online: https://qol.eortc.org/questionnaire/qlq-info25/ (accessed on 19 July 2024).
- Langius, J.A.E.; van Dijk, A.M.; Doornaert, P.; Kruizenga, H.M.; Langendijk, J.A.; Leemans, C.R.; Weijs, P.J.M.; Leeuw, I.M.V.-D. More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr. Cancer 2013, 65, 76–83. [Google Scholar] [CrossRef]
- Nunnally, J.C.; Bernstein, I.H. Psychometric Theory; McGraw-Hill: New York, NY, USA, 1994. [Google Scholar]
- Cook, F.; Rodriguez, J.M.; McCaul, L.K. Malnutrition, nutrition support and dietary intervention: The role of the dietitian supporting patients with head and neck cancer. Br. Dent. J. 2022, 233, 757–764. [Google Scholar] [CrossRef] [PubMed]
- Kenny, E.; Touger-Decker, R.; August, D.A. Structured review of the value added by the registered dietitian to the care of gastrointestinal cancer patients. Nutr. Clin. Pract. 2021, 36, 606–628. [Google Scholar] [CrossRef] [PubMed]
- Eraslan, P.; Tufan, G. Cancer information overload may be a crucial determinant of adjuvant aromatase inhibitor adherence. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 7053–7062. [Google Scholar] [CrossRef] [PubMed]
- Posma, E.R.; van Weert, J.C.; Jansen, J.; Bensing, J.M. Older cancer patients’ information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals. BMC Nurs. 2009, 8, 1. [Google Scholar] [CrossRef] [PubMed]
- Keaver, L.; O’Callaghan, N.; Douglas, P. Nutrition support and intervention preferences of cancer survivors. J. Hum. Nutr. Diet. 2023, 36, 526–539. [Google Scholar] [CrossRef]
- Takata, N.; Kikuchi, S.; Kuroda, S.; Tanabe, S.; Maeda, N.; Noma, K.; Takahashi, A.; Umeda, Y.; Shikata, K.; Ozaki, K.; et al. Effect of patient-participation continuous nutritional counseling in gastric cancer patients who underwent gastrectomy. Ann. Sur. Oncol. 2023, 30, 1110–1118. [Google Scholar] [CrossRef]
- Donohoe, C.L.; Healy, L.A.; Fanning, M.; Doyle, S.L.; Hugh, A.M.; Moore, J.; Reynolds, J.V. Impact of supplemental home enteral feeding postesophagectomy on nutrition, body composition, quality of life, and patient satisfaction. Dis. Esophagus 2017, 30, 1–9. [Google Scholar] [CrossRef]
- Dashti, H.S.; Godbole, M.; Chen, A.; Mogensen, K.M.; Leong, A.; Burns, D.L.; Winkler, M.F.; Saxena, R.; Compher, C. Sleep patterns of patients receiving home parenteral nutrition: A home-based observational study. J. Parenter. Enter. Nutr. 2022, 46, 1699–1708. [Google Scholar] [CrossRef]
- Sandrucci, S.; Cotogni, P.; De Zolt Ponte, B. Impact of Artificial Nutrition on Postoperative Complications. Healthcare 2020, 8, 559. [Google Scholar] [CrossRef]
- Shrestha, A.; Martin, C.; Burton, M.; Walters, S.; Collins, K.; Wyld, L. Quality of life versus length of life considerations in cancer patients: A systematic literature review. Psycho Oncol. 2019, 28, 1367–1380. [Google Scholar] [CrossRef]
- de Ligt, K.M.; Aaronson, N.K.; Liegl, G.; Nolte, S.; EORTC Quality of Life Group. Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: A cross-sectional panel research study. Qual Life Res. 2023, 32, 2477–2487. [Google Scholar] [CrossRef] [PubMed]
- Tarar, A.H.; Shaloom, A. Cancer and Quality of Life: Importance of Gender and Marital Adjustment in Psycho-Social Oncology. Pak. Armed Forces Med. J. 2020, 70, 734–739. [Google Scholar]
- Jehn, P.; Spalthoff, S.; Lentge, F.; Zeller, A.N.; Tavassol, F.; Neuhaus, M.T.; Korn, P. Postoperative quality of life and therapy-related impairments of oral cancer in relation to time–distance since treatment. J. Cancer Surviv. 2022, 16, 1366–1378. [Google Scholar] [CrossRef] [PubMed]
- Orell, H.; Schwab, U.; Saarilahti, K.; Österlund, P.; Ravasco, P.; Mäkitie, A. Nutritional counseling for head and neck cancer patients undergoing (chemo) radiotherapy—A prospective randomized trial. Front. Nutr. 2019, 6, 22. [Google Scholar] [CrossRef]
- Van der Werf, A.; Langius, J.A.E.; Beeker, A.; Ten Tije, A.J.; Vulink, A.J.; Haringhuizen, A.; Berkhof, J.; van der Vliet, H.J.; Verheul, H.M.W.; de van der Schueren, M.A.E. The effect of nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: A randomized controlled trial. Clin. Nutr. 2020, 39, 3005–3013. [Google Scholar] [CrossRef]
- Ho, Y.W.; Yeh, K.Y.; Hsueh, S.W.; Hung, C.Y.; Lu, C.H.; Tsang, N.M.; Wang, H.M.; Hung, Y.S.; Chou, W.C. Impact of early nutrition counseling in head and neck cancer patients with normal nutritional status. Support. Care Cancer 2021, 29, 2777–2785. [Google Scholar] [CrossRef]
- Ramondt, S.; Ramírez, A.S. Assessing the impact of the public nutrition information environment: Adapting the cancer information overload scale to measure diet information overload. Patient Educ. Couns. 2019, 102, 37–42. [Google Scholar] [CrossRef]
- Padilla, G.V. Psychological Aspects of Nutrition and Cancer. Surg. Oncol. Clin. N. 1986, 66, 1121–1135. [Google Scholar] [CrossRef] [PubMed]
- Jankowski, M.; Qelaj, A.; Klek, S.; Murawa, D.; Nartowicz, M.; Patela, Z.; Mańkowska-Wierzbicka, D.; Kapała, A.; Kuczyńska, B.; Zegarski, W. The role of comprehensive nutritional care in cancer patients. Nowotw. J. Oncol. 2021, 71, 158–161. [Google Scholar] [CrossRef]
- Collins, R.; Hunt, A.; Quinn, C.; Martyr, A.; Pentecost, C.; Clare, L. Methods and approaches for enhancing communication with people with moderate-to-severe dementia that can facilitate their inclusion in research and service evaluation: Findings from the IDEAL programme. Dementia 2022, 21, 1135–1153. [Google Scholar] [CrossRef]
- Sullivan, E.S.; Rice, N.; Kingston, E.; Kelly, A.; Reynolds, J.V.; Feighan, J.; Power, D.G.; Ryan, A.M. A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey. Clin. Nutr. ESPEN 2021, 41, 331–339. [Google Scholar] [CrossRef] [PubMed]
- Trujillo, E.B.; Dixon, S.W.; Claghorn, K.; Levin, R.M.; Mills, J.B.; Spees, C.K. Closing the Gap in Nutrition Care at Outpatient Cancer Centers: Ongoing Initiatives of the Oncology Nutrition Dietetic Practice Group. J. Acad. Nutr. Diet. 2018, 118, 749–760. [Google Scholar] [CrossRef] [PubMed]
- van Dongen, S.I.; de Nooijer, K.; Cramm, J.M.; Francke, A.L.; Oldenmenger, W.H.; Korfage, I.J.; E Witkamp, F.; Stoevelaar, R.; van der Heide, A.; Rietjens, J.A. Self-management of patients with advanced cancer: A systematic review of experiences and attitudes. Palliat. Med. 2020, 34, 160–178. [Google Scholar] [CrossRef]
- Afshar, N.; English, D.R.; Milne, R.L. Rural–urban residence and cancer survival in high-income countries: A systematic review. Cancer 2019, 125, 2172–2184. [Google Scholar] [CrossRef] [PubMed]
- Payne, S.; Jarrett, N.; Jeffs, D.; Brown, L. Implications of social isolation during cancer treatment.: The implications of residence away from home during cancer treatment on patients’ experiences: A comparative study. Health Place 2021, 7, 273–282. [Google Scholar] [CrossRef]
- Carnahan, L.R.; Rauscher, G.H.; Watson, K.S.; Altfeld, S.; Zimmermann, K.; Ferrans, C.E.; Molina, Y. Comparing the roles of social context, networks, and perceived social functioning with health-related quality of life among self-reported rural female cancer survivors. Support. Care Cancer 2021, 29, 331–340. [Google Scholar] [CrossRef]
- Konieczny, M.; Cipora, E.; Sygit, K.; Fal, A. Quality of Life of Women with Breast Cancer and Socio-Demographic Factors. Asian Pac. J. Cancer Prev. 2020, 21, 185–193. [Google Scholar] [CrossRef]
- Fiscella, K.; Goodwin, M.A.; Stange, K.C. Does patient educational level affect office visits to family physicians? J. Natl. Med. Assoc. 2002, 94, 157–165. [Google Scholar]
- Avancini, A.; Pala, V.; Trestini, I.; Tregnago, D.; Mariani, L.; Sieri, S.; Krogh, V.; Boresta, M.; Milella, M.; Pilotto, S.; et al. Exercise levels and preferences in cancer patients: A cross-sectional study. Int. J. Environ. Res. Public Health 2020, 17, 5351. [Google Scholar] [CrossRef]
- Nilsen, M.L.; Moskovitz, J.; Lyu, L.; Harrison, C.; Randazza, E.; Peddada, S.D.; Johnson, J.T. Health literacy: Impact on quality of life in head and neck cancer survivors. Laryngoscope 2020, 130, 2354–2359. [Google Scholar] [CrossRef]
Characteristics | Number (%) | ||
---|---|---|---|
Gender | Woman | 58 (53.7%) | |
Man | 50 (46.29%) | ||
Education level | Higher | 49 (45.37%) | |
General secondary | 36 (33.33%) | ||
Vocational secondary | 22 (20.37%) | ||
Primary | 1 (0.93%) | ||
Employment | Full-time permanent | 28 (25.93%) | |
Part-time permanent | 4 (3.70%) | ||
Full- or parti-time temporary | 5 (4.63%) | ||
Pension | 7 (6.48%) | ||
Retirement | 50 (46.30%) | ||
Not employed | 14 (12.96%) | ||
Place of residence | Rural area | 36 (33.33%) | |
Town, up to 20,000 inhabitants | 14 (12.96%) | ||
City, 20,000 to 100,000 inhabitants | 21 (19.44%) | ||
City, 100,000 to 500,000 inhabitants | 5 (4.63%) | ||
City, over 500,000 inhabitants | 32 (29.63%) | ||
>10% weight loss | Yes | 57 (52.78%) | |
No | 51 (47.22%) | ||
Economic situation | Good | 25 (23.15%) | |
Rather good | 40 (37.04%) | ||
Bad | 20 (18.52%) | ||
Rather bad | 10 (9.26%) | ||
Difficult to say | 13 (12.04%) | ||
Reduced food intake | Yes | 60 (55.56%) | |
No | 48 (44.44%) | ||
Patients soliciting nutritional information | Yes | 71 (68%) | |
No | 33 (31%) | ||
Types of nutrition support | Oral nutrition | 80 (74.07%) | |
Enteral nutrition | 28 (25.92%) | ||
Seeking consultation with a dietitian | Yes | 67 (62.04) | |
No | 41 (37.96%) | ||
Visited a dietitian | Yes | 67 (62.03%) | |
No | 41 (37.96%) | ||
Mean ± SD | 95% CI | Median * (IQR) | |
Age | 58.20 ± 14.38 | 55.44–60.97 | 60 (21.75) |
% Weight loss | 9.52 ± 8.84 | 7.82–11.23 | 9.95 (14.73) |
BMI | 24.31 ± 4.82 | 23.38–25.24 | 23.49 (7.28) |
Cancer Site According to ICD 10 | Name | Number (%) |
---|---|---|
C04 | Malignant neoplasm of floor of mouth | 10 (9.26) |
C14 | Malignant neoplasm of other and ill-defined sites in the lip, oral cavity, and pharynx | 16 (14.81) |
C15 | Malignant neoplasm of esophagus | 10 (9.26) |
C16 | Malignant neoplasm of stomach | 5 (4.63) |
C17 | Malignant neoplasm of small intestine | 1 (0.93) |
C18 | Malignant neoplasm of colon | 4 (3.70) |
C22 | Malignant neoplasm of liver and intrahepatic bile ducts | 4 (3.70) |
C24 | Malignant neoplasm of other and unspecified parts of biliary tract | 1 (0.93) |
C25 | Malignant neoplasm of pancreas | 3 (2.78) |
C32 | Malignant neoplasm of larynx | 20 (18.52) |
C34 | Malignant neoplasm of bronchus and lung | 4 (3.70) |
C50 | Malignant neoplasm of breast | 10 (9.26) |
C54 | Malignant neoplasm of corpus uteri | 1 (0.93) |
C56 | Malignant neoplasm of ovary | 11 (10.18) |
C61 | Malignant neoplasm of prostate | 8 (7.41) |
Measures | Subdomain | Mean Score ± SD | Median (IQR) * | 95%CI | Cronbach’s Alpha Coefficient |
---|---|---|---|---|---|
Functional scales | Physical | 65.56 ± 26.09 | 73.33 (40.0) | 60.58–70.53 | 0.82 |
Role | 56.33 ± 34.39 | 66.67 (50.0) | 49.77–62.89 | 0.86 | |
Cognitive | 69.6 ± 27.70 | 75.0 (50.0) | 64.31–74.88 | 0.51 | |
Emotional | 59.34 ± 28.09 | 66.67 (37.5) | 53.98–64.69 | 0.66 | |
Social | 49.54 ± 30.95 | 50.0 (33.33) | 43.63–55.44 | 0.71 | |
Global health status | 44.68 ± 21.36 | 41.67 (29.17) | 40.60–48.75 | - | |
Symptom scales | Fatigue | 48.46 ± 29.20 | 44.44 (33.33) | 42.89–54.03 | 0.70 |
Pain | 42.90 ± 34.35 | 33.33 (58.33) | 36.35–49.45 | 0.88 | |
Vomiting/nausea | 10.34 ± 17.16 | 0.0 (16.67) | 7.07–13.61 | 0.58 | |
Single-item measures | Dyspnea | 19.14 ± 29.25 | 0.0 (33.33) | 13.56–24.72 | - |
Insomnia | 46.30 ± 33.75 | 33.33 (33.33) | 39.86–52.73 | - | |
Appetite loss | 27.16 ± 31.62 | 33.33 (33.33) | 21.13–33.19 | - | |
Constipation | 24.38 ± 31.11 | 0 (33.33) | 18.45–30.32 | - | |
Diarrhea | 17.90 ± 30.38 | 0 (33.33) | 12.11–23.70 | - | |
Financial difficulties | 35.49 ± 35.38 | 33.33 (66.67) | 28.74–42.24 | - |
Measures | Subdomain | Female (n = 58) | Male (n = 50) | p-Value | ||||
---|---|---|---|---|---|---|---|---|
Mean Score ± SD | Median (IQR) | 95%CI | Mean Score ± SD | Median (IQR) | 95%CI | |||
Functional scales | Physical | 62.53 ± 24.43 | 63.33 (46.67) * | 40–86.67 | 69.07 ± 27.73 | 80 (40) * | 53.33–93.33 | 0.0836 |
Role | 52.59 ± 33.16 | 66.67 (33.33) * | 33.33–66.67 | 60.67 ± 35.6 | 66.67 (66.67) * | 33.33–100 | 0.1974 | |
Cognitive | 61.78 ± 28.1 | 66.67 (50) * | 33.33–83.33 | 78.67 ± 24.52 | 83.33 (33.33) * | 66.67–100 | 0.0011 | |
Emotional | 50.29 ± 28.57 | 50 (33.33) | 33.33–66.67 | 69.83 ± 23.74 | 75 (33.33) * | 58.33–91.67 | 0.0002 | |
Social | 43.68 ± 30.08 | 33.33 (50) * | 16.67–66.67 | 56.33 ± 30.84 | 66.67 (50) * | 33.33–83.33 | 0.0267 | |
Global health status | 38.51 ± 18.59 | 33.33 (25) * | 25–50 | 51.83 ± 22.29 | 50 (33.33) | 33.33–66.67 | 0.0029 | |
Symptom scales | Fatigue | 56.90 ± 28.16 | 55.56 (44.44) * | 33.33–77.78 | 38.67 ± 27.51 | 33.33 (33.33) * | 22.22–55.56 | 0.0008 |
Pain | 45.69 ± 34.42 | 33.33 (66.67) * | 16.67–83.33 | 39.67 ± 34.32 | 33.33 (66.67) * | 0–66.67 | 0.3686 | |
Vomiting/ nausea | 10.63 ± 17.85 | 0 (16.67) * | 0–16.67 | 10 ± 16.5 | 0 (16.67) * | 0–16.67 | 0.8703 | |
Single-item measures | Dyspnea | 22.41 ± 32.07 | 0 (33.33) * | 0–33.33 | 15.33 ± 25.39 | 0 (33.33) * | 0–33.33 | 0.2695 |
Insomnia | 51.15 ± 33.75 | 50 (33.33) * | 33.33–66.67 | 40.67 ± 33.19 | 33.33 (66.67) * | 0–66.67 | 0.1109 | |
Appetite loss | 28.16 ± 31.72 | 33.33 (33.33) * | 0–33.33 | 26 ± 31.79 | 16.67 (33.33) * | 0–33.33 | 0.6607 | |
Constipation | 22.41 ± 30.2 | 0 (33.33) * | 0–33.33 | 26.67 ± 32.3 | 16.67 (33.33) * | 0–33.33 | 0.4562 | |
Diarrhea | 20.69 ± 32.34 | 0 (33.33) * | 0–33.33 | 14.67 ± 27.9 | 0 (33.33) * | 0–33.33 | 0.3182 | |
Financial difficulties | 40.8 ± 38.51 | 33.33 (66.67) * | 0–66.67 | 29.33 ± 30.6 | 33.33 (33.33) * | 0–33.33 | 0.1626 |
Measures | Subdomain | Group 1 (n = 60) | Group 2 (n = 48) | p-Value | ||||
---|---|---|---|---|---|---|---|---|
Mean Score ± SD | Median (IQR) | 95%CI | Mean Score ± SD | Median (IQR) | 95%CI | |||
Functional scales | Physical | 63 ± 25.41 | 66.67 (43.33) * | 43.33–86.67 | 68.75 ± 26.85 | 80 (33.33) * | 53.33–86.67 | 0.1488 |
Role | 55 ± 34.62 | 66.67 (50) * | 33.33–83.33 | 57.99 ± 34.38 | 66.67 (50) * | 33.33–83.33 | 0.6340 | |
Cognitive | 60.56 ± 27.61 | 66.67 (50) * | 33.33–83.33 | 80.9 ± 23.57 | 83.33 (33.33) * | 66.67–100 | 0.0001 | |
Emotional | 54.17 ± 28.48 | 58.33 (41.67) * | 33.33–75 | 65.8 ± 26.48 | 66.67 (25) * | 58.33–83.33 | 0.0236 | |
Social | 46.11 ± 32.09 | 41.67 (50) * | 16.67–66.67 | 53.82 ± 29.22 | 66.67 (41.67) * | 33.33–75 | 0.1848 | |
Global health status | 40.42 ± 20.23 | 41.67 (25) | 25–50 | 50 ± 21.74 | 50 (33.33) | 33.33–66.67 | 0.0198 | |
Symptom scales | Fatigue | 51.3 ± 27.38 | 44.44 (33.33) * | 33.33–66.67 | 44.91 ± 31.26 | 38.89 (44.44) * | 22.22–66.67 | 0.2140 |
Pain | 49.17 ± 32.68 | 33.33 (50) * | 33.33–83.33 | 35.07 ± 35.1 | 33.33 (50) * | 0–50 | 0.0324 | |
Vomiting/nausea | 12.22 ± 18.38 | 0 (16.67) * | 0–16.67 | 7.99 ± 15.37 | 0 (16.67) * | 0–16.67 | 0.3553 | |
Single-item measures | Dyspnea | 23.89 ± 32.53 | 0 (33.33) * | 0–33.33 | 13.19 ± 23.56 | 0 (33.33) * | 0–33.33 | 0.1378 |
Insomnia | 53.33 ± 34.83 | 66.67 (33.33) * | 33.33–66.67 | 37.5 ± 30.46 | 33.33 (66.67) * | 0–66.67 | 0.0204 | |
Appetite loss | 37.78 ± 33.88 | 33.33 (66.67) * | 0–66.67 | 13.89 ± 22.63 | 0 (33.33) * | 0–33.33 | 0.0002 | |
Constipation | 25.56 ± 32.11 | 0 (33.33) * | 0–33.33 | 22.92 ± 30.1 | 0 (33.33) * | 0–33.33 | 0.7338 | |
Diarrhea | 18.33 ± 31.55 | 0 (33.33) * | 0–33.33 | 17.36 ± 29.16 | 0 (33.33) * | 0–33.33 | 0.9630 | |
Financial difficulties | 37.22 ± 36.36 | 33.33 (66.67) * | 0–66.67 | 33.33 ± 34.38 | 33.33 (33.33) * | 0–33.33 | 0.6362 |
Measures | Subdomain | Group 1 (n = 67) | Group 2 (n = 41) | p-Value | ||||
---|---|---|---|---|---|---|---|---|
Mean Score ± SD | Median (IQR) | 95%CI | Mean Score ± SD | Median (IQR) | 95%CI | |||
Functional scales | Physical | 64.58 ± 25.56 | 73.33 (40) * | 46.67–86.67 | 67.15 ± 27.18 | 73.33 (53.33) * | 40–93.33 | 0.4783 |
Role | 49 ± 36.22 | 50 (66.67) * | 16.67–83.33 | 68.29 ± 27.59 | 66.67 (50) * | 50–100 | 0.0087 | |
Cognitive | 64.43 ± 29.86 | 66.67 (66.67) * | 33.33–100 | 78.05 ± 21.55 | 83.33 (33.33) * | 66.67–100 | 0.0299 | |
Emotional | 55.97 ± 28.49 | 58.33 (33.33) * | 41.67–75 | 64.84 ± 26.84 | 66.67 (41.67) * | 41.67–83.33 | 0.1263 | |
Social | 45.27 ± 31.36 | 33.33 (50) * | 16.67–66.67 | 56.5 ± 29.32 | 66.67 (50) * | 33.33–83.33 | 0.0790 | |
Global health status | 41.79 ± 19.81 | 41.67 (16.67) * | 33.33–50 | 49.39 ± 23.15 | 50 (33.33) * | 33.33–66.67 | 0.0632 | |
Symptom scales | Fatigue | 53.23 ± 28.59 | 44.44 (44.44) * | 33.33–77.78 | 40.65 ± 28.83 | 33.33 (33.33) * | 22.22–55.56 | 0.0292 |
Pain | 48.01 ± 35.71 | 50 (66.67) * | 16.67–83.33 | 34.55 ± 30.59 | 33.33 (16.67) * | 16.67–33.33 | 0.0707 | |
Vomiting/nausea | 13.18 ± 19.58 | 0 (16.67) * | 0–16.67 | 5.69 ± 10.94 | 0 (16.67) * | 0–16.67 | 0.1194 | |
Single-item measures | Dyspnea | 22.89 ± 31.36 | 0 (33.33) * | 0–33.33 | 13.01 ± 24.58 | 0 (33.33) * | 0–33.33 | 0.1676 |
Insomnia | 48.76 ± 31.42 | 33.33 (33.33) * | 33.33–66.67 | 42.28 ± 37.29 | 33.33 (66.67) * | 0–66.67 | 0.3051 | |
Appetite loss | 33.33 ± 33.83 | 33.33 (66.67) * | 0–66.67 | 17.07 ± 24.86 | 0 (33.33) * | 0–33.33 | 0.0181 | |
Constipation | 25.37 ± 31.3 | 0 (33.33) * | 0–33.33 | 22.76 ± 31.13 | 0 (33.33) * | 0–33.33 | 0.6440 | |
Diarrhea | 21.39 ± 32.15 | 0 (33.33) * | 0–33.33 | 12.2 ± 26.62 | 0 (0) * | 0–0 | 0.1454 | |
Financial difficulties | 38.81 ± 35.1 | 33.33 (66.67) * | 0–66.67 | 30.08 ± 35.59 | 33.33 (33.33) * | 0–33.33 | 0.1705 |
Measures | Subdomain | Group 1 (n = 71) | Group 2 (n = 37) | p-Value | ||||
---|---|---|---|---|---|---|---|---|
Mean Score ± SD | Median (IQR) | 95%CI | Mean Score ± SD | Median (IQR) | 95%CI | |||
Functional scales | Physical | 61.31 ± 27.94 | 60 (46.67) * | 40–86.67 | 73.69 ± 20.06 | 80 (40) * | 53.33–93.33 | 0.0354 |
Role | 50.47 ± 34.15 | 50 (50) * | 16.67–66.67 | 67.57 ± 32.38 | 66.67 (50) * | 50–100 | 0.0127 | |
Cognitive | 63.85 ± 28.73 | 66.67 (50) * | 33.33–83.33 | 80.63 ± 22.05 | 83.33 (33.33) * | 66.67–100 | 0.0027 | |
Emotional | 54.11 ± 28.31 | 58.33 (41.67) * | 33.33–75 | 69.37 ± 25.08 | 75 (50) * | 41.67–91.67 | 0.0029 | |
Social | 43.19 ± 30.42 | 33.33 (50) * | 16.67–66.67 | 61.71 ± 28.56 | 66.67 (50) * | 33.33–83.33 | 0.0025 | |
Global health status | 40.96 ± 19.3 | 33.33 (25) * | 25–50 | 25.23 ± 27.67 | 33.33 (33.33) | 0–33.33 | 0.0161 | |
Symptom scales | Fatigue | 55.09 ± 29.6 | 55.56 (44.44) * | 33.33–77.78 | 30.63 ± 32.04 | 33.33 (50) * | 0–50 | 0.0006 |
Pain | 49.30 ± 33.97 | 33.33 (66.67) * | 16.67–83.33 | 8.56 ± 17.4 | 0 (16.67) * | 0–16.67 | 0.0031 | |
Vomiting/nausea | 11.27 ± 17.08 | 0 (16.67) * | 0–16.67 | 18.92 ± 30.97 | 0 (33.33) * | 0–33.33 | 0.4523 | |
Single-item measures | Dyspnea | 19.25 ± 28.54 | 0 (33.33) * | 0–33.33 | 36.94 ± 31.21 | 33.33 (66.67) * | 0–66.67 | 0.7441 |
Insomnia | 51.17 ± 34.19 | 66.67 (33.33) * | 33.33–66.67 | 31.53 ± 36.81 | 33.33 (66.67) * | 0–66.67 | 0.0277 | |
Appetite loss | 24.88 ± 28.57 | 33.33 (33.33) * | 0–33.33 | 20.72 ± 28.71 | 0 (33.33) * | 0–33.33 | 0.6421 | |
Constipation | 26.29 ± 32.33 | 0 (33.33) * | 0–33.33 | 11.71 ± 22.52 | 0 (33.33) * | 0–33.33 | 0.5225 | |
Diarrhea | 21.13 ± 33.45 | 0 (33.33) * | 0–33.33 | 25.23 ± 27.67 | 33.33 (33.33) * | 0–33.33 | 0.3717 | |
Financial difficulties | 40.85 ± 37.88 | 33.33 (66.67) * | 0–66.67 | 30.63 ± 32.04 | 33.33 (50) * | 0–50 | 0.0502 |
Unstandardized Coefficients | Standardized Coefficients β | p | ||
---|---|---|---|---|
β | SE | |||
Constant | 11.7007 | 0.0181 | ||
Functional scales—physical functioning | 0.4909 | 0.0744 | 0.4018 | <0.0001 |
Functional scales—social functioning | 0.2788 | 0.0765 | 0.1925 | 0.0004 |
Appetite loss | −0.1580 | 0.0735 | −0.10673 | 0.0340 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gliwska, E.; Głąbska, D.; Zaczek, Z.; Sobocki, J.; Guzek, D. Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients 2024, 16, 3207. https://doi.org/10.3390/nu16183207
Gliwska E, Głąbska D, Zaczek Z, Sobocki J, Guzek D. Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients. 2024; 16(18):3207. https://doi.org/10.3390/nu16183207
Chicago/Turabian StyleGliwska, Elwira, Dominika Głąbska, Zuzanna Zaczek, Jacek Sobocki, and Dominika Guzek. 2024. "Multifactorial Analysis of Influences on Quality of Life in Cancer Patients" Nutrients 16, no. 18: 3207. https://doi.org/10.3390/nu16183207
APA StyleGliwska, E., Głąbska, D., Zaczek, Z., Sobocki, J., & Guzek, D. (2024). Multifactorial Analysis of Influences on Quality of Life in Cancer Patients. Nutrients, 16(18), 3207. https://doi.org/10.3390/nu16183207